SMS Pharmaceuticals IPO listing price is ₹ 357.85, issue price is [●], and currently trading at ₹ 264.74 as on May 30, 2025. SMS Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
SMS Pharmaceuticals IPO is a Book Building listing on BSE,NSE exchange. The company is based in Hyderabad and caters to Pharmaceutical sector. Uti Securities is the merchant banker of SMS Pharmaceuticals IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
SMS Pharmaceuticals IPO offer price is ₹ 380.00 and got listed at ₹ 357.85. Read SMS Pharmaceuticals IPO details mentioned above.The IPO of SMS Pharmaceuticals Limited was listed on 28th February 2007. As of today, SMS Pharmaceuticals IPO is trading at ₹ 264.74, compared to the previous day’s close of ₹ 270.37. Read the report above for detailed IPO performance.
The issue price of SMS Pharmaceuticals IPO was [●] per equity share.
SMS Pharmaceuticals IPO was listed at ₹357.85 on the stock exchange on 28th February 2007. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of SMS Pharmaceuticals IPO is ₹ 264.74.
The 52-week high for SMS Pharmaceuticals IPO is ₹ 398.00, while the 52-week low is ₹ 175.25. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The SMS Pharmaceuticals IPO listed at ₹ 357.85 against the issue price of [●] per equity share, showing a listing day gain/loss of 319.85 (841.71%) , calculated by comparing the listing price to the issue price on the first day of trading.
The SMS Pharmaceuticals IPO stock moved from its listing price of ₹ 357.85 to the current price of ₹264.74 per equity share, reflecting a change of 639.81% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on SMS Pharmaceuticals IPO issue date of May 30, 2025 and CMP of ₹264.74, the estimated CAGR is approximately 11.21%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
SMS Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on SMS Pharmaceuticals Financial Review Page
Merchant Banker(s) of SMS Pharmaceuticals IPO: Uti Securities Limited
SMS Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
SMS Pharmaceuticals IPO listed at a listing price of 357.85 against the offer price of 380.00.
The current market price of SMS Pharmaceuticals is 264.74.
Why Us?